Committee D Members
Professor Gary McVeigh (Chair)
Professor of Cardiovascular Medicine, Queen's University Belfast and Consultant Physician, Belfast Health and Social Care Trust.
Gary is a Consultant Physician/Clinical Pharmacologist in the Belfast Health and Social Care Trust and Professor of Cardiovascular Medicine at Queen's University Belfast. Gary qualified from Queen's University and trained in Belfast and Minneapolis, USA. His major clinical and academic interests relate to cardiovascular complications associated with hypertension, diabetes mellitus and hyperlipidaemia. He has served as a member of the Executive Committee of the British Hypertension Society and is currently a member of the Guidelines and Information Committee. Gary was Regional Advisor for Northern Ireland and member of council for the Royal College of Physicians of Edinburgh. Gary chairs the Drugs and Therapeutics and New Drugs Committees and is the lead clinician for Therapeutic reviews in the Belfast Trust. He is the Training Programme Director for Clinical Pharmacology and Therapeutics in Northern Ireland.
Gary was former Vice Chair of Technology Appraisal Committee C and is currently Standing Chair of an internal Guideline Development Group for NICE.
Dr Lindsay Smith BSc MClinSci PhD MD FRCP FRCGP FHEA, (Vice Chair)
General Practitioner, Westlake Surgery, Somerset
Lindsay Smith has been a General Practitioner in Somerset for over 25 years. During this time he has undertaken primary care research through both academic departments and research general practices. He has previously been a Consultant senior lecturer in general practice and primary care. Currently he is an honorary senior lecturer at Bristol University, a GP Appraiser & CCG Patient Safety Lead. He has previously worked for NICE as a member of its TA appeals committee, its QOF advisory committee and various GDGs. He currently also is a member of its Quality Standards Advisory Committee, its CG Rapid Updates Standing Committee and a member of its Suspected Cancer GDG.
Dr Aomesh Bhatt
Director of Regulatory and Medical Affairs, Europe and North America, Reckitt Benckiser
Biography to follow
Dr Andrew Black
General Practitioner, Mortimer Medical Practice, Herefordshire
Andrew is a General Practitioner living and working in rural Herefordshire. He has been a partner in a large rural dispensing practice for the last 11 years. Prior to this he worked in Hospitals in London and Suffolk. In addition to his clinical work he has been involved in commissioning health services locally and worked on QOF at local, regional and national level. He has a particular interest in the application of evidence based medicine with a focus on cost-effectiveness. Andrew has recently graduated from Birmingham University with an MSc in Health Economics and Health Policy.
Professor David Bowen MA, MB BChir, MD, MRCP, FRCPath
Consultant Haematologist, Leeds Teaching Hospitals NHS trust
David qualified from Cambridge University and Middlesex Hospital, London. He trained in Haematology in London and Cardiff, with first his Consultant appointment in Dundee,then in Leeds where he has worked since 2005. His clinical expertise is in myeloid malignancies, with research interests in the etiology, molecular basis and clinical trial management of these diverse and rare cancers. He has chaired the National Cancer Research Institute Myelodysplastic Syndromes (MDS) subgroup and the British Committee for Standards in Haematology Guideline group for MDS. He co-chairs the European Myelodysplastic Syndrome Registry programme, accruing data for clinical effectiveness of management interventions in community-based practice.
Dr Matthew Bradley
Therapy Area Leader, Global Health Outcomes, GlaxoSmithKline
Matthew is a Therapy Area Leader for GlaxoSmithKline. Prior to this Matthew was a Value Demonstration leader for AstraZeneca Global Research and Development. He has previously been responsible for the coordination and delivery of an integrated programme of HTA across the Sanofi-Aventis portfolio in the UK and has also worked for Pfizer. Prior to moving into the Pharmaceutical Industry he was a Senior Research Fellow at the NHS Centre for Reviews and Dissemination (CRD), a lead reviewer for the Cochrane Collaboration, an author of strategic reports for the NHS HTA programme, the Department of Health and the Prime Minister's Office (UK Government). Matthew currently chairs the Association of British Pharmaceutical Industries TDA User Group. Matt is a peer reviewer for the NHS HTA programme and sits as required on the New Medicines Group (NMG) for the All Wales Medicines Strategy Group.
Dr Ian Campbell, OBE MD FRCP
Honorary Consultant Physician, Llandough Hospital, Cardiff
Ian was consultant in Thoracic Medicine in Cardiff from 1978 to 2010. His special interests are tuberculosis, smoking cessation/prevention, opportunist microbacterial lung diseases and pulmonary thrombo-embolism, areas in which he has designed and co-ordinated many local and multi-centre, clinical trials and written chapters in a number of textbooks. He chaired the Research Committee of the British Thoracic Society in 2003.
Although firmly committed to the NHS, Ian has had a regular session in private practice for over 24 years and has some experience also in medico-legal reporting.
Ian remains involved in clinical medicine, as a member of the National Speciality Advisory Group in Respiratory Medicine (Wales), on the board of Trustees of the Britain-Nepal Medical Trust and is the Honorary Secretary of the Scadding-Morrsiton Davies Fellowship fund.
Tracey is joint chair of the Lancashire and South Cumbria Neurological Alliance and has a recently acquired a Diploma in Patient and Public Involvement in Healthcare. Before being appointed to the Appraisal Committee, Tracey served as a Patient / Carer Representative on two NICE Guideline Development Groups.
Tracey is employed by the MS Society but is currently on secondment to Neurological Commissioning Support Ltd. Prior to this, Tracey worked for 10 years as a Divisional Manager in a variety of acute hospital settings in the Northwest of England.
Dr Ian Davidson
Senior Lecturer in Physiotherapy, Manchester Metropolitan University
Ian has been a clinical and academic physiotherapist for 28 years. He has worked as an academic at the Manchester School of Physiotherapy (affiliated to the University of Manchester), the School of Nursing Midwifery and Social work at the University of Manchester and is currently working as a Senior Lecturer at the School of Physiotherapy at Manchester Metropolitan University. He has served on several professional committees and boards and is currently is a panel member of the fitness to practice committee at the Health Care and Professions Council (HCPC). His clinical interests are in musculo-skeletal and neurological disorders. His research interests centre on intervention studies assessing the effect of physiotherapy on stroke, Guillain-Barré syndrome and migraine headache.
Professor Simon Dixon
Professor of Health Economics, University of Sheffield
Simon Dixon is the Director of the Health Economics and Decision Science (HEDS) section of the School of Health and Related Research (ScHARR) within the University of Sheffield. Most of his work has examined the cost-effectiveness of health technologies. A separate stream of work examining the use of willingness to pay to value non-health benefits of health care is also ongoing. He undertakes work for the Department of Health's Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) based in Sheffield/York. He teaches on three masters programmes within ScHARR and supervises several PhD students.
Dr Martin Duerden
Assistant Medical Director, Betsi Cadwaladr University Health Board, North Wales
Martin qualified in medicine from Newcastle University in 1982 and has worked as a GP since 1986. He obtained a Masters qualification in public health at Cambridge University in 1997. He has had a longstanding interest in applying evidence-based medicine to prescribing and therapeutics. He has previously worked for the National Prescribing Centre and the Department of Medicines Management at Keele University. From 1999 he has worked as a part-time GP in Conwy, North Wales, and initially worked as Medical Director for Conwy Local Health Board. Following the reorganisation of health services in Wales in 2009 he is now Deputy Medical Director for the Health Board which manages all primary and secondary care NHS services in North Wales. He helped to organise and run the Diploma in Therapeutics at Cardiff University between 2005 and 2010, where he is an Honorary Senior Lecturer. He chaired the New Medicines Group for Wales from inauguration in 2007 through to 2010. He is a Clinical Adviser on prescribing and evidence-based medicine for the Royal College of GPs.
Senior Medical Statistician, Oxford Clinical Trials Research Unit
Susan is a senior medical statistician and the lead statistician of the Oxford Clinical Trials Research Unit (OCTRU), a UKCRC Registered Clinical Trials Unit. The scope of OCTRU is to design, conduct and report in both early and later phase clinical trials in surgery, musculoskeletal sciences, respiratory medicines, gastroenterology and oncology including development pathways and the evaluation of new health technologies in surgery and interventional procedures; trauma, rehabilitation and conservative management; respiratory medicine/intervention and randomised trials; pharmaceuticals, particularly in oncology; the management of inflammation; and biomarkers to refine treatment strategies.
Susan has a BSc in Mathematics from Durham University and an MSc in Biometry from the University of Reading. She has worked as a medical statistician within academia and has experience in the design, analysis and reporting of various clinical trials and epidemiological studies. Susan joined the Centre for Statistics in Medicine at the University of Oxford in January 2007 to work as part of a team of medical statisticians providing statistical support for clinical trials in oncology. In 2013 Susan was appointed to be the Statistical Lead of the Oxford Clinical Trials Research Unit (OCTRU). Susan provides statistical input into a variety of Phase I-IV clinical trials from providing advice early in the development of the research, through designing the trial for grant application, through set-up, data collection, analysis and publication. Susan provides statistical oversight of trials and staff in OCTRU. Susan also participates in the methodological research undertaken by the Centre for Statistics in Medicine.
Dr Alexander Dyker
Consultant Physician, Wolfson Unit of Clinical Pharmacology, University of Newcastle
Alexander studied Immunology and Medicine at the University of Glasgow training as a lecturer in Clinical Pharmacology, General Medicine and Stroke Medicine at the University Department of Medicine of the Western Infirmary Glasgow. In 2001 he was appointed as a Consultant Physician in Clinical Pharmacology, Stroke and General Medicine at the Freeman Hospital Newcastle upon Tyne. His clinical and research experience includes medicines management, acute treatments for stroke, treatment of hypertension and Research Ethics.
Christopher Earl RN MSc BA(Hons) TD
Surgical Care Practitioner, Wessex Neurological Centre at Southampton University Hospital
Christopher qualified as a nurse from Chesterfield Royal Hospital in Derbyshire in 1990 and specialised in theatre nursing soon after. He has worked in a variety of university and district general hospitals around England and Australia. Since 2002 Christopher has has worked as a surgical care practitioner, initially in organ transplantation then in neuro-spinal surgery where he currently works. In 2011, Christopher completed his MSc in Advanced Surgical Practice at Cardiff University where he is currently an alumni contributor to the same course. Christopher was recently appointed as an Honorary Visiting Fellow at Anglia Ruskin University. His current research interests include prevention of surgical site infection and patient outcomes following posterior spinal surgery. He is also a member of the MHRA committee on the safety of devices and a Major in the Territorial Army medical services.
Gillian Ells BPharm, PGDip MSc
Prescribing Advisor - Commissioning. Hastings and Rother Clinical Commissioning Group and Eastbourne, Hailsham and Seaford Clinical Commissioning Group
Gillian Ells is a pharmacist working for two primary care trusts on the south east coast of England. Her previous experience includes working in both the hospital and the community sector. She has spent the past 10 years in primary care as a pharmaceutical advisor and now specialises in the commissioning of new drug treatments and management of the local health economy drug formulary. Gillian has recently completed a Masters in Health Economics and Health Policy at Birmingham University.
Professor Paula Ghaneh
Professor and Honorary Consultant Surgeon, University of Liverpool
Paula Ghaneh is a Senior Lecturer in the School of Cancer Studies at the University of Liverpool and an Honorary Consultant Surgeon at the Royal Liverpool University Hospital. Her clinical specialty is hepato-pancreato-biliary surgery. Her research interests are pancreatic cancer and clinical trials. She is the Assistant Director of the Cancer Research UK Liverpool Cancer Trials Unit. She is a member of the NCRI pancreatic cancer subgroup.
Susan Griffin, MSc BSc
Research Fellow, Centre for Health Economics, University of York
Susan joined the Centre for Health Economics, University of York in 2002 and holds a BSc in Economics and an MSc in Health Economics. In 2008 Susan became a Research Council UK Academic Fellow in Health Economics and Public Health. Her research interests include the use of decision-analytic models in cost-effectiveness analysis, the use of evidence synthesis techniques and value of information analysis. Susan has worked on economic evaluations in the fields of cardiovascular disease, HIV/AIDS, cancer and mental health. Susan is currently researching the application of methods for economic evaluation in the field of public health.
Professor Carol Haigh
Professor in Nursing, Manchester Metropolitan University
Carol is the Professor in Nursing at Manchester Metropolitan University. From a clinical background in orthopaedic trauma, Carol moved into post registration education in 1989. She developed and ran an MSc in Pain Management at the University of Salford before joining MMU as Professor in Nursing. Her PhD centred on osteoporosis and her other research interests include pain management, patient experience and organization of care. She has published widely on the subjects of pain management, research methods and ethical issues especially those surrounding the use of the Internet for research. Carol is the Associate Editor for the Clinical Issues of the Journal of Clinical Nursing. She is also an elected Steering Committee member of the Royal College of Nursing Research Society and a fellow of the Royal Statistical Society.
Professor John Henderson MD FRCP FRCPCH FRCPEd
Professor of Paediatric Respiratory Medicine, University of Bristol and Bristol Royal Hospital for Children
John is a paediatrician with a major research interest in the epidemiology of asthma and allergy in children. He is Co-Director of the Avon Longitudinal Study of Parents and Children (ALSPAC) and co-ordinates the respiratory and allergy research programmes in this large, longitudinal birth cohort study. His clinical interest are the management of difficult asthma, sleep-related breathing disorders and long term ventilation support of children with respiratory failure. He is a member of the British Thoracic Society and Scottish Intercollegiate Guideline Network asthma guidelines development group.
Dr Paul Hepple
General Practitioner, Muirhouse Medical Group
Paul has been a General Practitioner partner in a large teaching and research practice in Edinburgh for the past 16 years. His previous posts include Foundation Programme Director and currently he works as a GP trainer in his practice. He enjoys teaching evidence-based medicine and critical appraisal to junior doctors. He has been a member of the NICE guidelines development group on psoriasis which published its recommendations in 2012. He has worked as a referee for the British Journal of General Practice and the Health Technology Assessment programme at the National Institute of Health Research. Before training to be a doctor Paul worked in hospital management in London.
Professor John Hutton
Professor of Health Economics, University of York
John manages a programme of research on health care innovation and evaluation of health technologies at YHEC. He holds a chair in health economics in the Department of Health Sciences at the University of York. Previous positions have included Director of European Operations for MEDTAP International and Senior Research Fellow in the Centre for Health Economics at York. He is a founding Editor of Health Economics. Other roles include acting as a non-executive director of the NHS Innovation Hub for Yorkshire and the Humber, non-executive director and Vice Chair of the York Hospitals NHS Foundation Trust.
Professor Peter Jones
Emeritus Professor of Statistics, Keele University
Peter has recently retired as Pro Vice-Chancellor for Research and Enterprise at Keele. Other roles have included Dean of Natural Sciences and Head of the Mathematics Department. His research interests are in the design of clinical trials and modelling genetic effects on severity and susceptibility of disease. He is a non executive director of the Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust in Oswestry and a governor of Newcastle under Lyme School.
Professor Steven Julious
Reader in Medical Statistics, University of Sheffield
After completing his first degree at Manchester and masters at Reading, Steven's first role was at the University of Southampton where he worked for a number of years before entering the pharmaceutical industry. He completed his PhD part time at University College London while working in his previous role at GlaxoSmithKline, before joining the University of Sheffield in 2004 where he is currently a Senior Lecturer in Medical Statistics. Steven was editor of the journal Pharmaceutical Statistics and has a research interest in early phase trials and clinical trial design.
Dr Tim Kinnaird
Lead Interventional Cardiologist, University Hospital of Wales, Cardiff
Tim is a consultant cardiologist at the University Hospital of Wales, Cardiff. He qualified from Cardiff University in 1992 and subsequently trained in London, Vancouver and Washington before returning to Cardiff in 2007. He is the lead interventional cardiologist in the trust and has a research interest in clinical and basic science aspects of interventional cardiology including stem cells for the heart and the complications of coronary intervention. As well as his clinical roles he has a long standing interest in new drugs and their appraisal. He is a member of the trust's Medicines Management Committee and chairs the New Cardiovascular Drugs Group in Wales.
Warren Linley BSc (Hons) MSc MRPharmS
Senior Research Fellow, Centre for Health Economics and Medicines Evaluation, Bangor University.
Warren is a registered pharmacist and a health economist. He has worked in the new medicines arena for over 10 years. Following a brief spell in the pharmaceutical industry Warren joined the National Prescribing Centre (NPC) in 2001. Here he was responsible for producing evidence-based reviews of new medicines that were expected to have a significant clinical, financial or service impact for local NHS organisations. Since 2007 he has conducted reviews of the clinical and health economic evidence submitted by pharmaceutical companies to the All Wales Medicines Strategy Group.
Malcolm works as an independent consultant. His background is in systems analysis, analysing what people and organisations providing health care do and also what information they need to do it. Since the late 1990s, he has specialised in information governance, working mostly for National bodies in England and Scotland specifying the rules that control who accesses confidential patient information in systems. This involves interpreting and applying law and policy, consulting clinicians and patient/public representatives.
Malcolm has completed a PhD in Bioethics and Medical Jurisprudence. His thesis explores how, in a democracy, we should decide how resources are allocated to health care, analysing competing theories from philosophy, economics and other disciplines. In 2011, he co-authored the Royal College of General Practitioners' guidance on ethical commissioning (“Making Difficult Choices”).
Professor Oluwafemi Oyebode
Professor of Psychiatry & Consultant Psychiatrist, The National Centre for Mental Health
Femi graduated in Medicine in 1977. He has been Consultant Psychiatrist in Birmingham since 1986. He is currently Professor of Psychiatry at the University of Birmingham. He is on the Editorial Boards of the British Journal of Psychiatry, the Psychiatric Bulletin and Advances in Psychiatric Treatment. His research interests include Clinical Psychopathology, Medical Humanities and Medical Ethics.
Dr John Radford
Director of Public Health, Rotherham Primary Care Trust and MBC
John was a GP in Sheffield before undertaking Public Health training. He was previously Director of Public Health in Doncaster and has been Director of Public Health and Medical Director including prescribing lead in Rotherham from 2002 to 2011. Following the devolution of Primary Care Trust provider arms and the development of GP commissioning he now works as the joint Director of Public Health for Rotherham MBC and the PCT.
Dr Radford continues to work in General Practice. His interests include evidence based prescribing and untoward incident analysis and learning. He chairs the Child Death Overview Panel and is a member of Rotherham Safeguarding Children Board.
Dr Murray Smith
Associate Professor in Social Research in Medicines and Health, University of Nottingham
Murray joined the University of Nottingham in 2010, having previously been with HERU at the University of Aberdeen for three years and prior to that at the University of Sydney in the Department of Econometrics for almost 20 years. His research interests include microeconometrics, health economics and mathematical statistics. His recent research has focussed on the quality of use of pharmaceutical medicines in chronic disease, with analyses that utilise prescribing data drawn from large database general practice patient records.
Professor Carolyn Young
Consultant neurologist, Walton Centre for Neurology & Neurosurgery
Carolyn is enthusiastically committed to the care of people with disabling, chronic neurological diseases. She is a consultant neurologist, who dual trained in rehabilitation medicine. She has developed large multidisciplinary MS and MND services and continues to do weekly specialist clinics in MS and MND. She also does regular clinics for people with post polio syndrome and spinal conditions. For over 15 years she was the sole consultant for an inpatient rehabilitation unit.
Since the 1980s she has been based at the Walton Centre for Neurology and Neurosurgery in Liverpool, an integrated, supra-regional neurosciences centre. She has researched a variety of treatments for neurological conditions, principally in MS and MND. Carolyn has published on patient-reported outcome measures and now leads a major study on quality of life in neurological conditions. Among her many publications she has co-authored several Cochrane reviews and she is on the Editorial Board of the Cochrane Neuromuscular Diseases Group.
This page was last updated: 28 February 2014